Financhill
Sell
18

KROS Quote, Financials, Valuation and Earnings

Last price:
$13.41
Seasonality move :
-0.3%
Day range:
$13.24 - $13.77
52-week range:
$9.12 - $72.37
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
2.42x
P/B ratio:
0.75x
Volume:
414.7K
Avg. volume:
605.4K
1-year change:
-68.68%
Market cap:
$544.7M
Revenue:
$3.6M
EPS (TTM):
-$0.18

Earnings Data

Next earnings date for KROS
Aug 07
2025
Most recent earnings per share
$3.62
Beat by $3.61
(May 6/2025)
Consensus Estimate
$0.01
(May 6/2025)

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

KROS Quarterly Earnings History

Date Quarter Revenue Forecast Actual Revenue Reported EPS Consensus EPS Beat/Miss
09/30/2025 Q3 $2.9M -- -- -$1.03 --
08/07/2025 Q2 $3.8M -- -- -$1.15 --
05/06/2025 Q1 $56.6M $211.2M $3.62 $0.01 $3.61
02/26/2025 Q4 $37.3M $3M -$1.14 -$0.43 -$0.71
11/06/2024 Q3 -- $388K -$1.41 -$1.28 -$0.13
08/07/2024 Q2 -- $37K -$1.25 -$1.25 $0.00
05/08/2024 Q1 -- $83K -$1.21 -$1.33 $0.12
02/28/2024 Q4 -- $143K -$1.34 -$1.39 $0.05
11/06/2023 Q3 -- $8K -$1.33 -$1.35 $0.02
08/07/2023 Q2 $144.4K -- -$1.27 -$1.35 $0.08
05/04/2023 Q1 -- -- -$1.26 -- --
03/03/2023 Q4 -- -- -$1.09 -- --
11/03/2022 Q3 -- -- -$0.92 -- --
08/04/2022 Q2 -- -- -$1.13 -- --
05/05/2022 Q1 -- -- -$1.01 -- --
03/09/2022 Q4 -- $20M -$0.30 -- --
11/04/2021 Q3 -- -- -$0.87 -- --
08/05/2021 Q2 -- $100K -$0.67 -- --
05/06/2021 Q1 -- -- -$0.68 -- --
03/25/2021 Q4 -- -- -$0.49 -- --
11/10/2020 Q3 -- -- -$0.60 -- --
08/13/2020 Q2 -- -- -$0.62 -- --
05/22/2020 Q1 -- -- -$0.70 -- --
12/31/2019 Q4 -- $2.5M -$0.18 -- --
09/30/2019 Q3 -- $2.5M -$0.45 -- --
06/30/2019 Q2 -- $2.5M -$0.37 -- --
03/31/2019 Q1 -- $2.5M -$0.41 -- --

Keros Therapeutics Earnings Questions

  • How Much did Keros Therapeutics Generate in Revenue Last Quarter?

    Keros Therapeutics reported $211.2M worth of top line sales in its most recent quarter.

  • Did Keros Therapeutics Beat Earnings Last Quarter?

    Keros Therapeutics announced earnings per share of $3.62 which represents a beat of analyst forecast a $0.01 per share.

  • Is Keros Therapeutics Profitable?

    Keros Therapeutics reported -- that represents -- per share over the last quarter.

  • What is the Analyst Consensus for Keros Therapeutics EPS Next Year?

    Keros Therapeutics's earnings are forecast to decrease from -$5.00 per share to -$4.12 per share next year representing a decrease of -35.91%.

  • When is Keros Therapeutics's Earnings Date?

    Keros Therapeutics's next earnings date is August 7, 2025.

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Where Will Hershey Stock Be In 1 Year?
Where Will Hershey Stock Be In 1 Year?

Chocolate stocks used to be the epitome of sleepy stability,…

Where Will KNOT Stock Be In 1 Year?
Where Will KNOT Stock Be In 1 Year?

In the case of KNOT Offshore Partners (KNOP), most headlines…

Why Is Goldman Sachs Stock Up So Much?
Why Is Goldman Sachs Stock Up So Much?

Investment banking giant Goldman Sachs (NYSE:GS) has sharply outperformed the…

Stock Ideas

Buy
63
Is NVDA Stock a Buy?

Market Cap: $3.8T
P/E Ratio: 53x

Buy
60
Is MSFT Stock a Buy?

Market Cap: $3.7T
P/E Ratio: 42x

Sell
48
Is AAPL Stock a Buy?

Market Cap: $3.2T
P/E Ratio: 35x

Alerts

Sell
18
CNC alert for Jul 3

Centene [CNC] is up 2.31% over the past day.

Sell
12
MOH alert for Jul 3

Molina Healthcare [MOH] is up 0.22% over the past day.

Buy
67
GBX alert for Jul 3

Greenbrier Companies [GBX] is up 0.3% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock